ECMO-assisted valve-in-valve transcatheter aortic valve replacement following surgical aortic valve replacement failure in triple-positive antiphospholipid syndrome and systemic lupus erythematosus-associated libman-sacks endocarditis: a case report
Year: 2026
Type: article
Study design: Case Report
Abstract: BACKGROUND: Libman-Sacks endocarditis (LSE) is a non-infective valvular manifestation of systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), affecting 15-30% of patients with APS. Characterized by sterile vegetations predisposing to thromboembolism and valvular dysfunction, optimal anticoagulation and intervention strategies remain challenging, particularly with rapid prosthetic failure. CASE PRESENTATION: A 63-year-old African American man with a 20-year history of SLE and triple-positive APS presented with cardiogenic shock five months after surgical aortic valve replacement (SAVR) for LSE. Echocardiography revealed severe bioprosthetic obstruction (mean gradient 79.6 mmHg, valve area 0.30 cm²). Given prohibitive redo surgical risk (STS-PROM 18.2%), he underwent ECMO-assisted valve-in-valve transcatheter aortic valve replacement (TAVR) with a 26 mm Edwards SAPIEN 3 valve. Left ventricular ejection fraction improved from 25-29% to 55-59% at 4.5 months, sustained at 50-54% at 8-month follow-up. He remained stable on warfarin (INR 2-3), hydroxychloroquine, and rituximab under multidisciplinary care. DISCUSSION: This case demonstrates diagnostic challenges differentiating LSE from bioprosthetic valve thrombosis (BPVT); a competing diagnosis that could not be excluded without histopathologic confirmation, critical limitations of DOACs in triple-positive APS, and feasibility of ECMO-supported TAVR as an exceptional rescue strategy. Rituximab was administered for refractory APS, though its independent contribution to the favorable outcome cannot be determined. CONCLUSION: To our knowledge, this is the first reported ECMO-assisted valve-in-valve TAVR following SAVR failure in APS/SLE-associated LSE. It emphasizes multidisciplinary care, warfarin-based anticoagulation, immunosuppression escalation, and long-term surveillance for complex autoimmune valvular disease.
Source: The Egyptian Heart Journal
Institution: HCA Healthcare
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7234607381
